Cidara Tackles Anti-Fungal Therapies, Takes Aim at Universal Flu Vaccine 0 01.05.2019 03:00 Feedity.com While few drug developers are focused on multi-drug resistant invasive fungal infections, San Diego-based Cidara Therapeutics is in the thick of the fight with its Phase III lead antifungal rezafungin. Moscow.media Частные объявления сегодня Rss.plus Все новости за 24 часа